+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 19Years +
All Genders
ID07786012

Randomized Trial Comparing Intrathecal Buprenorphine and Morphine for Pain Relief After Elective Cesarean Delivery

Led by Icahn School of Medicine at Mount Sinai · Updated on 2026-10-16

180

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are comparing two types of pain relief medications, intrathecal buprenorphine and morphine, for pregnant patients undergoing elective cesarean delivery. The study aims to evaluate how these drugs perform in managing post-surgical pain after cesarean section. It is a randomized, phase 4 trial focused on treatment during the immediate postoperative period. Participants are randomly assigned to receive either 60 mcg of intrathecal buprenorphine or 125 mcg of intrathecal morphine as part of their spinal anesthesia during cesarean delivery. These treatments are given once during the spinal procedure, and the study compares their effects on pain relief and recovery. During the study, participants will be monitored for pain levels, use of additional morphine equivalents at 24, 48, and 72 hours after spinal administration, and side effects like itching. Recovery quality is assessed using a specific questionnaire at multiple time points. The study includes careful monitoring during the post-anesthesia care unit stay and follow-up for up to three days after surgery.

CONDITIONS

Brief Title

BUprenorphine Versus Morphine for Postcesarean Analgesia (BUMP)

Research Team

D

Daniel Katz

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here